Tiaki Therapeutics has appointed Suzanne Bruhn as CEO. Bruhn, a serial biotech CEO, arrives at Tiaki shortly after the Alzheimer’s...
This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
The Park Square team is thrilled to support Deep Genomics and their unique, AI-driven approach to discovering and developing genetic...
Park Square is pleased to announce the placement of Michael Cox as Vice President, Clinical Development at Puma Biotechnology. Puma...